Developmental aspects of the basal ganglia and therapeutic perspectives

Epileptic Disorders

Volumn 4, Issue SUPPL. 3, 2002, Pages

  Velíšková, Jana ^a   Claudio, Olga I ^a   Galanopoulou, Aristea S ^a   Kyrozis, Andreas ^a   Lado, Fred A ^a   Ravizza, Teresa ^a   Velíšek, Libor ^a   Moshé, Solomon L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Basal ganglia; Development; Epilepsy; GABA; Seizures; Sex; Substantia nigra; Testosterone

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; SEX HORMONE;

BASAL GANGLION; BRAIN DEVELOPMENT; CONFERENCE PAPER; EPILEPSY; EPILEPTOGENESIS; GABAERGIC SYSTEM; HUMAN; NERVE CELL NETWORK; NEUROANATOMY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SEX DIFFERENCE; SUBSTANTIA NIGRA;

ANIMALS; BASAL GANGLIA; CONVULSANTS; EPILEPSY; FEMALE; MALE; RATS; SEIZURES; SEX CHARACTERISTICS; SUBSTANTIA NIGRA;

EID: 0036921340     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (82)

1. Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease. Ann Rev Neurosci 1999; 22: 123-44.
2. Winkler C, Bentlage C, Nikkhah G, etal. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol 1999; 155: 165-86.
3. Plenz D, Kital ST. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus [see comments]. Nature 1999; 400: 677-82.
4. A receptors by estradiol: a clue for CNS changes occurring at menopause. Cell Mol Neurobiol 1996; 16: 199-212.
5. Burbaud P, Bonnet B, Guehl D, et al. Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey. Brain Res 1998; 780: 102-7.
6. Iadarola MJ, Gale K. Substantia nigra: site of anticonvulsant activity mediated by γ-aminobutyric acid. Science 1982; 218: 1237-40.
7. Depaulis A, Snead OCI, Marescaux C, et al. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res 1989; 498: 64-72.
8. De Sarro G, Meldrum B, Reavill C. Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra. Eur J Pharmacol 1984; 106: 175-9.
9. A receptors in seizures of adult rats. Brain Res 1989; 480: 378-82.
10. A receptors involved in seizures. Eur J Pharmacol 1996; 309: 167-73.
11. Xie XH, Tietz EI, Rosenberg HC. Anti-pentylenetetrazol effect of intranigral 2-amino-7-phosphonoheptanoate attenuated by muscimol. Brain Res 1991; 544: 331-4.
12. Turski L, Cavalheiro EA, Turski WA, et al. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-Daspartate. Neuroscience 1986; 18: 61-77.
13. Deransart C, Le-Pham BT, Hirsch E, et al. Inhibition of the substantia nigra suppresses absences and clonic seizures in audiogenic rats, but not tonic seizures: evidence for seizure specificity of the nigral control. Neuroscience 2001, 105: 203-11.
14. Löscher W, Czuczwar SJ, Jäckel R, et al. Effect of microinjections of y-vinyl GABA or isoniazid into substantia nigra on the development of amygdala kindling in rats. Exp Neurol 1987; 95: 622-38.
15. Engel J, Jr., Wolfson L, Brown L. Anatomical correlates of electrical and behavioral events related to amygdaloid kindling. Ann Neurol 1978; 3: 538-44.
16. Eells JB, Clough RW, Miller JW, et al. Fos expression and 2-deoxyglucose uptake following seizures in developing genetically epilepsy-prone rats. Brain Res Bull 2000; 52: 379-89.
17. Nunes ML, Miller A, Velíšková J. Mapping of brain metabolism during flurothyl seizures using the [14C]-2-deoxyglucose technique. VI Workshop on Neurobiology of Epilepsy 2001; 76.
18. Pazdernik TL, Cross RS, Giesler M, et al. Changes in local cerebral glucose utilization induced by convulsants. Neuroscience 1985; 14: 823-35.
19. Nehlig A, Vergnes M, Boyet S, et al. Metabolic activity is increased in discrete brain regions before the occurrence of spike-and-wave discharges in weanling rats with genetic absence epilepsy. Dev Brain Res 1998; 108: 69-75.
20. Sawamura A, Hashizume K, Yoshida K, et al. Kainic acid-induced substantia nigra seizure in rats: behavior, EEG and metabolism. Brain Res 2001; 911: 89-95.
21. Ingvar M. Cerebral blood flow and metabolic rate during seizures. Relationship to epileptic brain damage. Ann NY Acad Sci 1986; 462: 194-206.
22. Ingvar M. Seizure-induced damage in the substantia nigra pars reticulata: lesions in the frontal cortex prior to the seizure period mitigate the damage. Exp Brain Res 1989; 75: 369-74.
23. Towfighi J, Kofke WA, O'Connell BK, et al. Substantia nigra lesions in mercaptopropionic acid induced status epilepticus: a light and electron microscopic study. Acta Neuropathol 1989; 77: 612-20.
24. Schmidt-Kastner R, Heim C, Sontag KH. Damage of substantia nigra pars reticulata during pilocarpine-induced status epilepticus in the rat: immunohistochemical study of neurons, astrocytes and serum-protein extravasation. Exp Brain Res 1991; 86: 125-40.
25. White LE, Price JL. The functional anatomy of limbic status epilepticus in the rat. I. Patterns of 14C-2-deoxyglucose uptake and Fos immunocytochemistry. J Neurosci 1993; 13: 4787-809.
26. Labiner DM, Butler LS, Cao Z, et al. Induction of c-fos mRNA by kindled seizures: complex relationship with neuronal burst firing. J Neurosci 1993; 13: 744-51.
27. Shehab S, Julyan E. Induction of Fos-like immunoreactivity in the basal ganglia by ether anaesthesia: effects of injections of muscimol in rostral versus caudal substantia nigra pars reticulata. Exp Brain Res 2002; 142: 227-40.
28. Thompson K, Anantharam V, Behrstock S, et al. Conditionally Immortalized Cell Lines, Engineered to Produce and Release GABA, Modulate the Development of Behavioral Seizures. Exp Neurol 2000; 161: 481-9.
29. Ableitner A, Herz A. Changes in local cerebral glucose utilization induced by the beta-carbolines FG 7142 and DMCM reveal brain structures involved in the control of anxiety and seizure activity. J Neurosci 1987; 7: 1047-55.
30. Fan XD, Zhang X, Yu PH, et al. Induction of preconvulsive behavior and Fos expression by dopamine-induced nigral lesion in the rat. Brain Res 1997; 751: 31-6.
31. Hajós M, Greenfield SA. Topographic heterogeneity of substantia nigra neurons: diversity in intrinsic membrane properties and synaptic inputs. Neuroscience 1993; 55: 919-34.
32. Bartholini G, Scatton B, Zivkovic KG, et al. GABA receptor agonists as a new therapeutic class. In: Bartholini G, Bossi L, Lloyd KG, et al. Epilepsy and GABA receptor agonists. New York: Raven Press, 1985: 1-30.
33. Meldrum BS. GABA-agonists as antiepileptic agents. In: Costa E. GABA and benzodiazepine receptor. New York: Raven Press, 1981: 207-17.
34. Jung MJ, Lippert B, Metcalf BW, et al. γ-vinyl GABA (4-aminohex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 1977; 29: 797-802.
35. Unnerstall JR, Kuhar MJ, Niehoff DL, et al. Benzodiazepine receptors are coupled to a subpopulation of GABA receptors: evidence from a quantitative autoradiographic study. J Pharm Exp Ther 1981; 218: 797-804.
36. Olsen RW, Snowhill EW, Wamsley JK. Autoradiographic localization of low affinity GABA receptors with [3H] bicuculline methochloride. Europ J Pharmacol 1984; 99: 247-8.
37. Palacios JM, Wamsley JK, Kuhar MJ. High affinity GABA receptors-autoradiographic localization. Brain Res 1981; 222: 285-330.
38. McCabe RT, Wamsley JK. Autoradiographic localization of subcomponents of the macromolecular GABA receptor complex. Life Sci 1986; 39: 1937-45.
39. Heyer EJ, Nowak LM, Macdonald RL. Bicuculline: a convulsant with synaptic and nonsynaptic actions. Neurology 1981; 31: 1381-90.
40. Allan RD, Dickenson HW, Duke RK, et al. ZAPA, a substrate for the neuronal high affinity GABA uptake system in rat brain slices. Neurochem Int 1991; 18: 63-7.
41. Krogsgaard-Larsen P. THIP, a specific and clinically active GABA agonist. Neuropharmacology 1984; 23: 837-8.
42. Arbilla S, Allen J, Wick A, et al. High-affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors. Eur J Pharmacol 1986; 130: 257-63.
43. A receptor subunit composition on the action of allosteric modulators of γ-aminobutyric acid-gated C-currents. Mol Pharmacol 1991; 39: 691-6.
44. Velíšková J, Löscher W, Moshé SL. Regional and age specific effects of zolpidem microinfusions in the substantia nigra on seizures. Epilepsy Res 1998; 30: 107-14.
45. Saxena NC, Macdonald RL. Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms. Mol Pharmacol 1996; 49: 567-79.
46. A receptors on channel function. Neuron 1990; 5: 703-11.
47. Verdoorn A, Draguhn A, Ymer S, et al. Functional properties of recombinant rat GABAA receptors depend upon subunit composition. Neuron 1990; 4: 919-28.
48. Wafford K, Whiting P, Kemp J. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant γaminobutyric acid A receptor subtypes. Mol Pharmacol 1992; 43: 240-4.
49. A receptor heterogeneity. Nature 1988; 335: 76-9.
50. A receptor subunits in the substantia nigra is developmentally regulated and region-specific. Ital J Neurol Sci 1998; 19: 205-10.
51. Moshé SL, Brown LL, Kubová H, et al. Maturation and segregation of brain networks that modify seizures. Brain Res 1994; 665: 141-6.
52. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 1992; 12: 1040-62.
53. Schwarzer C, Berresheim U, Pirker S, et al. Distribution of the major gamma-aminobutyric acid(A) receptor subunits in the basal ganglia and associated limbic brain areas of the adult rat. J Comp Neurol 2001; 433: 526-49.
54. Velíšková J, Fabiánová K, Liptáková K, Liptáková S. Gender differences in the GAD67 immunoreactivity in the substantia nigra pars reticulata. Epilepsia 1998; 39: 28.
55. Galanopoulou A, Moshé SL. Sex differences in the expression of the potassium-chloride cotransporter 2 (KCC2) mRNA in the substantia nigra reticulata of developing rats. Soc Neurosci Abst 2001; 27: Program No. 263.9.
56. Rivera C, Voipio J, Payne JA, et al. The K+/Cl-co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 1999; 397: 251-5.
57. Garcia-Cairasco N, Terra VC, Doretto MC. Midbrain substrates of audiogenic seizures in rats. Behav Brain Res 1993; 58: 57-67.
58. Gale K. Role of the substantia nigra in GABA-mediated anticonvulsant actions. Adv Neurol 1986; 44: 343-64.
59. Depaulis A, Liu Z, Vergnes M, et al. Suppression of spontaneous generalized non-convulsive seizures in the rat by microinjection of GABA antagonists into the superior colliculus. Epilepsy Res 1990; 5: 192-8.
60. Gale K, Pazos A, Maggio R, et al. Blockade of GABA receptors in superior colliculus protects against focally evoked limbic motor seizures. Brain Res 1993; 603: 279-83.
61. Redgrave P, Marrow L, Dean P. Anticonvulsant role of nigrotectal projection in the maximal electroshock model of epilepsy - II. Pathways from substantia nigra pars lateralis and adjacent peripeduncular area to the dorsal midbrain. Neuroscience 1992; 46: 391-406.
62. Velíšková J, Moshé SL. Sexual dimorphism and developmental regulation of substantia nigra function. Ann Neurol 2001; 50: 596-601.
63. A agonists microinjected into rat substantia nigra: pro- and anticonvulsant actions. Epilepsia 1995; 36: 960-5.
64. Ojeda SR, Urbanski HF. Puberty in the rat. In: Knobil E, Neil J. The Physiology of Reproduction. New York: Raven Press, Ltd., 1994: 363-409.
65. Xu SG, Garant DS, Sperber EF, et al. The proconvulsant effect of nigral infusions of THIP on flurothyl-induced seizures in rat pups. Dev Brain Res 1992; 68: 275-7.
66. Sperber EF, Wong BY, Wurpel JN, et al. Nigral infusions of muscimol or bicuculline facilitate seizures in developing rats. Brain Res 1987; 465: 243-50.
67. Wurpel JND, Tempel A, Sperber EF, et al. Age-related changes of muscimol binding in the substantia nigra. Dev Brain Res 1988; 43: 305-8.
68. Claudio OI, Kyrozis A, Moshé SL. Muscimol depolarizes male and hyperpolarizes female substantia nigra pars reticulata neurons. Epilepsia 2001; 42: 12.
69. McEwen BS, Alves SE, Bulloch K, et al. Clinically relevant basic science studies of gender differences and sex hormone effects. Psychopharmacol Bull 1998; 34: 251-9.
70. Bixo M, Backstrom T, Winblad B, et al. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 1995; 55: 297-303.
71. Lyons KE, Hubble JP, Troster AI, et al. Gender differences in Parkinson's disease. Clin Neuropharmacol 1998; 21: 118-21.
72. Miller DB, Ali SF, O'Callaghan JP, et al. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann NY Acad Sci 1998; 844: 153-65.
73. Rivest R, Falardeau P, Di Paolo T. Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res 1995; 692: 269-72.
74. Vadasz C, Baker H, Fink SJ, et al. Genetic effects and sexual dimorphism in tyrosine hydroxylase activity in two mouse strains and their reciprocal F1 hybrids. J Neurogenet 1985; 2: 219-30.
75. Guivarc'h D, Vernier P, Vincent JD. Sex steroid hormones change the differential distribution of the isoforms of the D2 dopamine receptor messenger RNA in the rat brain. Neuroscience 1995; 69: 159-66.
76. Wilson MA. Gonadectomy and sex modulate spontaneous activity of substantia nigra pars reticulata neurons without modifying GABA/benzodiazepine responsiveness. Life Sci 1993; 53: 217-25.
77. Manev H, Pericic D. Sex difference in the turnover of GABA in the rat substantia nigra. J Neural Transm 1987; 70: 321-8.
78. Canonaco M, Tavolaro R, Facciolo RM, et al. Sexual dimorphism of GABAA receptor levels in subcortical brain regions of a woodland rodent (Apodemus sylvaticus). Brain Res Bull 1996; 40: 187-94.
79. Nicoletti F, Patti F, Ferrara N, et al. Comparative effects of estrogens and prolactin on nigral and striatal GAD activity. Brain Res 1982; 232: 238-41.
80. Gernert M, Loscher W. Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats. Eur J Pharmacol 2001; 432: 35-41.
81. Pfaff DW. Morphological changes in the brains of adult male rats after neonatal castration. J Endocrin 1966; 6: 415-6.
82. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th. New York: Academic Press, 1998.